These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8535773)

  • 61. [Hepatógenas cardiomyopathies].
    DIAZ-RUBIO M; JIMENEZ ORTA M; LAZARO P
    Rev Clin Esp; 1954 May; 53(3):161-7. PubMed ID: 13195056
    [No Abstract]   [Full Text] [Related]  

  • 62. The Nitric Oxide View: Perspectives and Applications.
    Maniscalco M
    Curr Med Chem; 2020; 27(42):7134-7135. PubMed ID: 33342396
    [No Abstract]   [Full Text] [Related]  

  • 63. [Etiology and pathogenesis of several liver diseases].
    BRUSSELMANS P
    Belg Tijdschr Geneesk; 1950 Nov; 6(21):977-84. PubMed ID: 14791262
    [No Abstract]   [Full Text] [Related]  

  • 64. NEW DEVELOPMENTS IN HEPATOLOGY.
    Starzl TE
    Nihon Shokaki Geka Gakkai Zasshi; 1979 Aug; 12(8):471-480. PubMed ID: 21499443
    [TBL] [Abstract][Full Text] [Related]  

  • 65. On the Use of Nitric Acid Issues in Chronic Diseases.
    Allaire PA
    Ill Indiana Med Surg J; 1847 Feb; 1(6):502-507. PubMed ID: 37262466
    [No Abstract]   [Full Text] [Related]  

  • 66. Antioxidant Activity, Metabolism, and Bioavailability of Polyphenols in the Diet of Animals.
    Bešlo D; Golubić N; Rastija V; Agić D; Karnaš M; Šubarić D; Lučić B
    Antioxidants (Basel); 2023 May; 12(6):. PubMed ID: 37371871
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS
    Lavin B; Eykyn TR; Phinikaridou A; Xavier A; Kumar S; Buqué X; Aspichueta P; Sing-Long C; Arrese M; Botnar RM; Andia ME
    NMR Biomed; 2023 Aug; 36(8):e4932. PubMed ID: 36940044
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.
    Kawamura A; Uojima H; Chuma M; Shao X; Hidaka H; Nakazawa T; Take A; Sakaguchi Y; Numata K; Kako M; Nozaki A; Azuma S; Horio K; Kusano C; Atsuda K
    BMC Cancer; 2022 Aug; 22(1):912. PubMed ID: 35999529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver.
    Ramos-Tovar E; Muriel P
    Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33333846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Air pollution exposure associates with increased risk of neonatal jaundice.
    Zhang L; Liu W; Hou K; Lin J; Song C; Zhou C; Huang B; Tong X; Wang J; Rhine W; Jiao Y; Wang Z; Ni R; Liu M; Zhang L; Wang Z; Wang Y; Li X; Liu S; Wang Y
    Nat Commun; 2019 Aug; 10(1):3741. PubMed ID: 31431616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pulmonary manifestations in a patient with transaldolase deficiency.
    Jassim N; Alghaihab M; Saleh SA; Alfadhel M; Wamelink MM; Eyaid W
    JIMD Rep; 2014; 12():47-50. PubMed ID: 23846909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatopulmonary syndrome induced by common bile duct ligation in a rabbit model: correlation between pulmonary vascular dilatation on thin-section CT and angiography and serum nitrite concentration or endothelial nitric oxide synthase (eNOS)1 expression.
    Lee KN; Yoon SK; Lee JW; Kim KN; Park BH; Kwak JY; Jeong JS; Kim YH
    Korean J Radiol; 2004; 5(3):149-56. PubMed ID: 15467411
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations.
    Trauner M
    Yale J Biol Med; 1997; 70(4):365-78. PubMed ID: 9626757
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pathophysiological and therapeutic implications of nitric oxide in hepatology].
    Battista S; Bar F; Pollet C; Mengozzi G; Molino G
    Minerva Gastroenterol Dietol; 2002 Dec; 48(4):309-18. PubMed ID: 16491056
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
    Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conservation of whole body nitric oxide metabolism in human alcoholic liver disease: implications for nitric oxide production.
    Demoncheaux EA; Elphick DA; Dürner MB; Higgins GE; Crowther D; Williams EJ; Higenbottam TW; Gleeson D
    Scand J Gastroenterol; 2006 Jul; 41(7):820-5. PubMed ID: 16785195
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
    Geier A; Fickert P; Trauner M
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):574-85. PubMed ID: 17008927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?
    Rasaratnam B; Connelly N; Chin-Dusting J
    Clin Sci (Lond); 2004 Nov; 107(5):425-34. PubMed ID: 15270715
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nitric oxide and liver disease.
    Abrams GA; Trauner M; Nathanson MH
    Gastroenterologist; 1995 Sep; 3(3):220-33. PubMed ID: 8535773
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.